NEW YORK (TheStreet) -- Monsanto  (MON) stock is declining by 1.14% to $89.86 in early afternoon trading on Wednesday.

On Thursday, a French court upheld a 2012 ruling that found the company was liable in the chemical poisoning of a farmer who claims to have experienced neurological problems due to Monsanto's Lasso weedkiller, according to Reuters

Monsanta, based in St. Louis, provides agricultural products for farmers worldwide. Among other products, it manufactures Roundup brand herbicides and provides lawn-and-garden herbicide products for the residential market. 

TheStreet's Bryan Ashenberg and Bob Lang of Trifecta Stocks have identified Monsanto as the "Chart of the Day." Here is what Ashenberg and Lang had to say about the company:

Stocks in the fertilizer space have struggled all year long with questions about demand and pricing issues. Monsanto, the creator of "Roundup" and other ground nutrients, has been hit hard and is under severe distribution. The company is trying to close a deal with the Swiss company Syngenta (SYT) , but that is now in question.

As we consider the general stock landscape after the recent carnage, some names have recovered well while others have not. Monsanto's performance has been dreadful. Stocks and options should be sold on any rally. As you can see in the chart, the channel is defined, but just recently, the stock was so weak it fell right through on increasing turnover. That is not a good sign, and we see that playing out in the very weak momentum indicators. High distribution plus poor price action equals avoid. For more analysis on MON, watch this video.

-Bryan Ashenberg and Bob Lang " Chart of the Week: MON " originally published on 09/16/15 on Trifecta Stocks.
 
Want more like this from Bryan Ashenberg and Bob Lang BEFORE your stock moves? Learn more about Trifecta Stocks now!
 
Separately, TheStreet Ratings team rates MONSANTO CO as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
 
"We rate MONSANTO CO (MON) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, expanding profit margins and notable return on equity. We feel its strengths outweigh the fact that the company shows weak operating cash flow."
 
You can view the full analysis from the report here: MON